GSK York RDC Solar Facility - 2.6 MW Solar PV in York, Pennsylvania

GSK York RDC Solar Facility is a 2.6 MW solar photovoltaic installation located in York, Pennsylvania, United States. Owned by GlaxoSmithKline Consumer Healthcare L P, the facility is operational and contributes to the company's renewable energy portfolio. As a medium-scale solar project, it aligns with the growing trend of corporate renewable energy procurement in the US. The facility operates under the regulatory framework of the US Inflation Reduction Act (IRA) and Pennsylvania's Alternative Energy Portfolio Standard (AEPS), which requires a certain percentage of electricity from renewable sources. Solar PV technology converts sunlight directly into electricity, and at 2.6 MW, this facility can power approximately 500 homes annually, reducing reliance on fossil fuels. Environmentally, the facility helps reduce greenhouse gas emissions and supports local grid stability. By generating clean energy on-site, GSK reduces its carbon footprint and contributes to Pennsylvania's renewable energy targets. The project also demonstrates the viability of solar energy in the Mid-Atlantic region, which has moderate solar insolation.

The facility is located in York, Pennsylvania, a region with moderate solar insolation. Solar PV installations like this one help reduce air pollution and greenhouse gas emissions by displacing fossil fuel generation. The project also minimizes land-use impact by utilizing existing industrial or commercial space, avoiding additional land disturbance.